BPC-157 is a synthetic pentadecapeptide derived from human gastric juice proteins. Below is a curated selection of peer-reviewed studies investigating its properties.
2025
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
PMC / Current Reviews in Musculoskeletal Medicine
This scoping review evaluates the molecular mechanisms, therapeutic potential, and safety profile of BPC-157 in musculoskeletal healing. It finds robust regenerative and cytoprotective effects in preclinical studies — including modulation of VEGFR2, ERK1/2, and nitric oxide signalling — while noting that human trial data remains minimal.
View Paper →2025
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
PMC / Orthopaedic Journal of Sports Medicine
This systematic review of 36 studies (1993–2024) synthesises BPC-157’s mechanism of action, musculoskeletal effects, metabolic profile, and safety data. It found improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injury models, with no adverse effects observed in preclinical safety studies.
View Paper →2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity
PMC / Biomedicines
This paper highlights the pleiotropic properties of BPC-157, including its stability in human gastric juice, its role as a cytoprotection mediator, and its broad beneficial activity across multiple organ systems including interactions with growth hormone, nitric oxide, and eicosanoid pathways.
View Paper →2025
Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Ischemia–Reperfusion Injury
PMC / Medicina
This study investigates BPC-157’s protective effects on distant organ damage following lower-extremity ischemia-reperfusion injury in rats. It demonstrates significant protective activity across liver, kidney, and lung tissue, supporting BPC-157’s role as a systemic cytoprotective agent beyond localised tissue repair.
View Paper →2021
Pentadecapeptide BPC 157 and the Central Nervous System
PMC / Neural Regeneration Research
This review focuses on BPC-157’s effects on CNS pathology, highlighting its ability to normalise disrupted neurotransmitter signalling involving dopamine, serotonin, and GABA. It also examines BPC-157’s role in stabilising acetylcholine receptors at the neuromuscular junction.
View Paper →2021
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Frontiers in Pharmacology
This review examines BPC-157’s efficacy across wound healing models, including its effectiveness in counteracting bleeding disorders, amputation injuries, and anticoagulant-induced complications. It demonstrates consistent wound-healing benefits via multiple routes of administration.
View Paper →